“…In addition, it has been shown that a TLR7 polymorphism is highly associated with human SLE (Wang et al, 2014;Tian et al, 2012). However, our previous and current data indicate that the conjugate did not show any ability to induce in vitro proliferation of human or murine B cells, while to the contrary other endosomal TLR7 or TLR9 ligands such as imidazoquinolines or CpG-ODNs did (Simchoni and Cunningham-Rundles, 2015). It is generally agreed that molecular structure, local amount, affinity for the receptors and time of the interaction may affect the quality and intensity of signals exerted by different ligands of the same TLR agonists: this could explain potential differences between the effects of modified adenines and other TLR7 ligands (Chang, 2010).…”